Kabanat — Cabazitaxel 60 mg
Kabanat is a next-generation taxane chemotherapy drug. Active ingredient: Cabazitaxel (60 mg).
Manufacturer: Natco Pharma (India). It is a generic equivalent of Jevtana.
Mechanism of Action:
Kabanat works by disrupting the microtubule network in cells, which is essential for mitotic and interphase cellular functions. It promotes the assembly of tubulin into stable microtubules and inhibits their disassembly, causing cancer cell death.
✅ Key Usage: Specifically designed for patients whose cancer has progressed despite previous treatment with Docetaxel.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 10.03.2026
What Customers Say
No reviews yet
Your review can be the first!